Strategy Builder COT Data Advanced News ResearchNew Earnings Calendar Economic Calendar

We use cookiesPrivacy Policy

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
BLS
COT
Economic Calendar

Learn

Service Guide
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

ResolvedStocks

Lifeward Shareholders Approve Strategic Partnership with Oramed to Secure $47 Million

First Detected: Mar 13, 2026, 12:18 PM

Last Update: 6 months ago

539 articles·78 stories

Event Summary

On March 13, Lifeward received shareholder approval to finalize a strategic partnership with Oramed. The partnership grants Lifeward access to up to $47 million in capital. Lifeward will integrate Oramed's POD™ oral delivery technology into its platform.

Timeline

BioHarvest Sciences Reports 37% Revenue Growth in 2025 as Losses Narrow

Mar 31, 2026, 8:46 PMImpact: 6

Bank of America Initiates MiniMed Coverage with Buy Rating and $27 Target

Mar 31, 2026, 8:33 PMImpact: 6

Minerva Neurosciences Initiates Phase 3 Trial for Schizophrenia Drug Roluperidone

Mar 31, 2026, 8:33 PMImpact: 6

BioPorto Submits FDA Pre-Submission for Adult NGAL Diagnostic Program

Mar 31, 2026, 4:00 PMImpact: 6

Gan & Lee’s Once-Weekly Insulin GZR4 Meets Primary Endpoints in Phase 3 Trials

Mar 31, 2026, 3:34 PMImpact: 7

MAIA Biotechnology Reports Positive Survival Data in Phase 2 Lung Cancer Trial

Mar 31, 2026, 1:33 PMImpact: 6

LifeMD Launches Telehealth Subscription for Wegovy in Partnership with Novo Nordisk

Mar 31, 2026, 1:01 PMImpact: 6

Nuwellis Pediatric Segment Reaches 50% of Total U.S. Revenue in 2025

Mar 31, 2026, 12:54 PMImpact: 6

DeFi Development Corp. Reports 442% Revenue Surge for FY 2025 Driven by Solana Strategy

Mar 30, 2026, 8:48 PMImpact: 7

Fortress Biotech Subsidiary Closes $205 Million Priority Review Voucher Sale

Mar 30, 2026, 8:18 PMImpact: 7

Kala Bio Transitions to Revenue Model with BIRA AI Platform Launch

Mar 30, 2026, 1:01 PMImpact: 6

Clearmind Medicine Completes Treatment for 18 Participants in Alcohol Use Disorder Trial

Mar 30, 2026, 12:48 PMImpact: 6

SeaStar Medical Reports Positive Clinical Data for QUELIMMUNE Pediatric Therapy

Mar 30, 2026, 12:32 PMImpact: 6

BioRestorative Reports Positive Phase 2 Clinical Data for BRTX-100 Stem Cell Therapy

Mar 30, 2026, 12:18 PMImpact: 7

Teva Gains FDA Approval for New Biosimilar and Regulatory Acceptance for Xolair Candidate

Mar 30, 2026, 12:17 PMImpact: 7

Unity Beats Q1 Guidance and Announces Strategic Pivot for Profitability

Mar 26, 2026, 8:39 PMImpact: 7

Zenas BioPharma Launches Concurrent Common Stock and Convertible Notes Offerings

Mar 26, 2026, 8:16 PMImpact: 6

Abbott Expands Chronic Care Portfolio with $23B Exact Sciences Deal and Positive Libre Data

Mar 26, 2026, 5:34 PMImpact: 7

Tevogen Bio Evaluates Niche CRO Acquisition to Drive Revenue Growth

Mar 26, 2026, 5:02 PMImpact: 6

Microbot Medical (MBOT) Shares Rise as LIBERTY System Completes World-First Robotic Procedures

Mar 26, 2026, 1:37 PMImpact: 6

Tivic Health Partners with NIAID to Evaluate Entolimod for Radiation Syndrome

Mar 26, 2026, 1:36 PMImpact: 6

NextPlat Expands Medication Fulfillment to All 50 U.S. States via Strategic Partnership

Mar 26, 2026, 1:31 PMImpact: 6

Emergent BioSolutions Secures Over $60 Million in Smallpox Countermeasure Contracts

Mar 25, 2026, 8:32 PMImpact: 6

Brenmiller Energy Achieves First Commercial Revenue with Flagship Project Delivery

Mar 25, 2026, 8:21 PMImpact: 6

Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock

Mar 25, 2026, 8:19 PMImpact: 6

BofA Initiates Coverage on Bicara Therapeutics with Buy Rating and $35 Target

Mar 25, 2026, 7:01 PMImpact: 6

FDA Approves Corcept Therapeutics' Lifyorli for Ovarian Cancer Treatment

Mar 25, 2026, 5:04 PMImpact: 8

Protalix 2026 Revenue Guidance Surpasses Expectations Despite FY25 Miss

Mar 24, 2026, 7:03 PMImpact: 6

Radiopharm Theranostics Eyes Pivotal Trial for RAD 101 Following Positive Data

Mar 24, 2026, 3:21 PMImpact: 6

Apimeds Pharmaceuticals Declares Material Breach in Merger Deal with Inscobee

Mar 24, 2026, 3:01 PMImpact: 6

NeuroSense Advances Toward Regulatory Milestones and Alzheimer's Readout

Mar 24, 2026, 1:17 PMImpact: 6

20/20 BioLabs Secures Exclusive U.S. License for ROKIT Healthcare’s CKD Prediction Tech

Mar 24, 2026, 12:49 PMImpact: 6

Silexion Therapeutics Receives Israeli Approval for Phase 2/3 Pancreatic Cancer Trial

Mar 24, 2026, 12:48 PMImpact: 6

Matricelf Partners with Sheba Medical Center for Spinal Cord Injury Clinical Trials

Mar 24, 2026, 12:23 PMImpact: 6

Gilead and Galapagos in Advanced Talks for Autoimmune T Cell Program

Mar 23, 2026, 10:47 PMImpact: 6

Apogee Therapeutics Upsizes Public Offering to $350 Million at $70 Per Share

Mar 23, 2026, 8:17 PMImpact: 6

William Blair Initiates Eupraxia Pharmaceuticals Coverage with $900M Sales Forecast

Mar 23, 2026, 6:37 PMImpact: 6

Embecta to Acquire Owen Mumford for $199.4 Million to Expand Drug-Delivery Portfolio

Mar 23, 2026, 5:52 PMImpact: 6

Gilead Sciences Confirms $2 Billion Acquisition of Ouro Medicines

Mar 23, 2026, 5:01 PMImpact: 7

RenovoRx Closes Oversubscribed $10 Million Private Placement to Fund Strategic Milestones

Mar 23, 2026, 2:09 PMImpact: 6

Linkers Industries Prices $16 Million Public Offering

Mar 23, 2026, 1:49 PMImpact: 6

Wellgistics Health Signs $105M LOI to Acquire Neuritek Therapeutics

Mar 23, 2026, 1:31 PMImpact: 6

ParaZero and Empery Digital Announce $29 Million in Registered Direct Offerings

Mar 23, 2026, 1:08 PMImpact: 6

Abbott Finalizes Acquisition of Exact Sciences to Lead Cancer Diagnostics Market

Mar 23, 2026, 1:03 PMImpact: 6

Alto Neuroscience Raises $120 Million to Advance ALTO-207 Development

Mar 23, 2026, 1:02 PMImpact: 6

Tarsus Pharmaceuticals Secures China Approval for TP-03, Triggers $15M Milestone Payment

Mar 23, 2026, 12:49 PMImpact: 6

Victory Holdings Acquires Dunn & Groux to Enter $190B Functional Beverage Market

Mar 23, 2026, 12:19 PMImpact: 6

InMed Pharmaceuticals Reports Positive Preclinical Results for Alzheimer's Drug INM-901

Mar 23, 2026, 12:04 PMImpact: 6

Lexicon and Novo Nordisk Launch Phase 1 Trial for Oral Obesity Drug LX9851

Mar 23, 2026, 12:03 PMImpact: 6

Price Impact

Since event start

LFWD+5.84%

ORMP+38.55%